Common acquired naevi (junctional / compound / intradermal)
Common melanocytic naevus ยท ordinary naevus ยท banal naevus ยท garden-variety mole
Common acquired naevi are benign clonal proliferations of melanocytes acquired through childhood, adolescence and early adulthood. The total naevus count plateaus around age 30-40 and slowly declines from middle age. Three histological subtypes โ junctional, compound and intradermal โ represent the natural maturation continuum of a single naevus over decades. Their importance in skin oncology is twofold: (1) the strongest single melanoma risk factor is total naevus count (and naevus count is incorporated in UK pre-test melanoma risk tools); (2) they are the principal benign differential for melanoma at biopsy.
Natural evolution
- Junctional naevus: flat, well-demarcated tan-brown macule; nests of melanocytes confined to the dermo-epidermal junction. Predominantly children and adolescents.
- Compound naevus: slightly elevated; combined junctional and dermal melanocyte populations. Young adults.
- Intradermal naevus: dome-shaped, often skin-coloured or lightly pigmented; melanocytes entirely within the dermis. Older adults.
- Maturation: surface flatness โ elevation; pigment loss; hair (terminal); fibrosis. Typical lifecycle 30-40 years.
- Total naevus count: peaks 20-30 years; declines from 40 onwards.
Genetics and biology
- ~80% of common naevi harbour somatic BRAF V600E mutation.
- A minority are NRAS-mutant — NRAS is the characteristic driver of congenital naevi.
- Single mutation followed by senescence / growth arrest underlies the small size and stability of naevi (unlike melanoma which acquires additional driver mutations).
- Heritable factors: total naevus count is heritable; MC1R variants increase number and atypia.
Clinical and dermoscopic features
- Symmetric in shape, colour, and structure.
- Well-demarcated border.
- Single dominant colour (light to medium brown typically).
- <6 mm diameter usually; can be larger in adolescents.
- Stable over time after age 30; concerning if new or changing in adults >40.
- Dermoscopy: globular, reticular, homogeneous patterns; symmetric; benign network with regular meshes; centrally hyperpigmented globules.
- Hair within naevus does not indicate atypia.
Melanoma risk
- Total naevus count is the strongest single risk factor for melanoma:
- >100 common naevi: relative risk ~7-fold.
- โฅ5 atypical / dysplastic naevi: relative risk ~6-fold.
- The risk attributable to naevus count is not eliminated by reducing the naevi themselves โ surveillance is the appropriate strategy.
- UK 2-week-wait NICE NG12 weighted 7-point checklist for melanoma considers changes in pre-existing naevi.
- Total body photography / dermoscopy with sequential imaging is NICE NG14-supported for high naevus-count / dysplastic naevus syndrome.
Red flags / when to biopsy
- Asymmetry, Border irregularity, Colour variation, Diameter >6 mm, Evolution (ABCDE).
- Glasgow 7-point checklist:
- Major (2 points each): change in size, change in shape, change in colour.
- Minor (1 point each): diameter โฅ7 mm, inflammation, oozing / crusting / bleeding, change in sensation.
- Score โฅ3 โ refer.
- New naevus appearing in adults >40 years.
- "Ugly duckling" โ a naevus that looks distinctly different from the patient's other naevi.
- Asymmetric dermoscopic features: atypical pigment network, blue-white veil, regression structures, atypical pseudopods / streaks / dots.
Management
- Stable, benign-appearing naevi: reassurance + skin self-examination education.
- Suspicious naevi: full excisional biopsy with 1-2 mm margin (NICE NG14).
- Cosmetic removal: shave excision for elevated intradermal naevi (counsel about pigment / hair regrowth).
- Avoid laser / cryotherapy / curettage on pigmented lesions โ destroys diagnostic histology.
- Surveillance for high-risk patients:
- Naevus count >100, atypical naevus syndrome, familial melanoma, prior melanoma.
- Annual total-body photography ยฑ sequential dermoscopy.
- UV photoprotection counselling.
- Counsel: lifelong surveillance; new naevus appearance in adults warrants assessment; ABCDE rule.
References
- Bauer J, Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. Pigment Cell Res. 2003;16:297-306.
- Pollock PM et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19-20.
- NICE NG14. Melanoma: assessment and management. London: NICE; 2015 (last updated 27 July 2022).
- NICE NG12. Suspected cancer: recognition and referral. London: NICE; 2015 (last updated 15 April 2026).
- Argenziano G et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting. J Am Acad Dermatol. 2003;48:679-693.
- Gandini S et al. Meta-analysis of risk factors for cutaneous melanoma. Number of nevi. Eur J Cancer. 2005;41:28-44.
Spot a correction?
If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.

